Pharmacokinetics of Saquinavir, Atazanavir, and Ritonavir in a Twice-Daily Boosted Double-Protease Inhibitor Regimen von VON HENTIG, Nils, MÜLLER, Axel, STASZEWSKI, Schlomo, ROTTMANN, Carsten, WOLF, Timo, LUTZ, Thomas, KLAUKE, Stephan, KUROWSKI, Michael, OERTEL, Bruno, DAUER, Brenda, HARDER, Sebastian

Volltext

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries von Zwahlen, Marcel, Harris, Ross, May, Margaret, Hogg, Robert, Costagliola, Dominique, de Wolf, Frank, Gill, John, Fätkenheuer, Gerd, Lewden, Charlotte, Saag, Mike, Staszewski, Sholmo, d'Arminio Monforte, Antonella, Casabona, Jordi, Lampe, Fiona, Justice, Amy, von Wyl, Viktor, Egger, Matthias

Volltext

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis von May, Margaret T, Sterne, Jonathan A C, Costagliola, Dominique, Sabin, Caroline A, Phillips, Andrew N, Justice, Amy C, Dabis, François, Gill, John, Lundgren, Jens, Hogg, Robert S, de Wolf, Frank, Fätkenheuer, Gerd, Staszewski, Schlomo, d'Arminio Monforte, Antonella, Egger, Matthias

Volltext

Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults von VON HENTIG, Nils, DAUER, Brenda, HABERI, Annette, KLAUKE, Stefan, LUTZ, Thomas, STASZEWSKI, Schlomo, HARDER, Sebastian

Volltext

The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy von Staszewski, Schlomo, Babacan, Errol, Stephan, Christoph, Haberl, Annette, Carlebach, Amina, Gute, Peter, Klauke, Stephan, Hermschulte, Yvonne, Stuermer, Martin, Dauer, Brenda

Volltext

Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ ritonavir von STEPHAN, Christoph, HENTIG, Nils V, KOURBETI, Irene, DAUER, Brenda, MÖSCH, Manfred, LUTZ, Thomas, KLAUKE, Stephan, HARDER, Sebastian, KUROWSKI, Michael, STASZEWSKI, Schlomo

Volltext

Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen von STÜRMER, Martin, DAUER, Brenda, MOESCH, Manfred, HABERL, Annette, MUELLER, Axel, LOCHER, Leo, KNECHT, Gaby, HANKE, Nora, DOERR, Hans W, STASZEWSKI, Schlomo

Volltext

Use of Viral Load Measured After 4 Weeks of Highly Active Antiretroviral Therapy to Predict Virologic Outcome at 24 Weeks for HIV-1–Positive Individuals von Smith, Colette J, Staszewski, Schlomo, Sabin, Caroline A, Nelson, Mark, Dauer, Brenda, Gute, Peter, Johnson, Margaret A, Phillips, Andrew N, Gazzard, Brian

Volltext

Definition of loss of virological response in trials of antiretroviral drugs von STASZEWSKI, Schlomo, SABIN, Caroline, DAUER, Brenda, LEPRI, Alessandro Cozzi, PHILLIPS, Andrew

Volltext

Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and... von Phillips, Andrew N., Staszewski, Schlomo, Lampe, Fiona, Youle, Michael S., Klauke, Stephan, Bickel, Markus, Sabin, Caroline A., Doerr, Hans Wilhelm, Johnson, Margaret A., Loveday, Clive, Miller, Veronica

Volltext